Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

James Latham revenue still in line with forecasts

(Sharecast News) - James Latham said in a trading update on Thursday that fiscal year revenue had remained in line with market forecasts, with stable cost prices seen for both timber and panels. The AIM-traded firm said ongoing shipping issues in the Red Sea, however, had led to delays and increased costs for certain imported products.

Despite that, the board said the situation was not currently a cause for significant concern, adding that sales volumes had mirrored those of the previous year.

While overheads had been effectively managed, James Latham said they had experienced a slight increase due to inflationary pressures.

Additionally, ongoing investments in depot enhancements to bolster service levels had contributed to the uptick.

The company anticipated that its profit before tax would align with market expectations, maintaining a strong balance sheet and cash position.

James Latham said it would release its preliminary results for the financial year ending 31 March on 27 June.

At 1225 GMT, shares in James Latham were flat at 1,125p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Agronomics investee Solar Foods raises EUR 8m
(Sharecast News) - Cellular agriculture investor Agronomics announced on Friday that its portfolio company Solar Foods had raised an additional €8m through Finnish investment organiser Springvest.
Thruvision FY24 adjusted underlying losses widen
(Sharecast News) - Security technology business Thruvision said on Friday that adjusted underlying losses had widened in FY24 as revenues fell.
Proteome Sciences secures contract win with US biopharmaceutical firm
(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's mass spectrometry services for the analysis of samples for an on-going clinical trial.
Loungers FY24 underlying earnings seen ahead of market expectations
(Sharecast News) - Bar and restaurant operator Loungers said on Friday that it had seen continued strong like-for-like sales growth in the 53 weeks ended 21 April and now expects full-year underlying earnings to come in ahead of expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.